Roy Winston Pacira Bio Sciences, Inc. (PCRX) insider trading activity

Roy Winston is Chief Medical Officer of Pacira BioSciences, Inc.. Currently has a direct ownership of 52,440 shares of PCRX, which is worth approximately $870,504. The most recent transaction as insider was on Aug 02, 2023, when has been sold 509 shares (Common Stock) at a price of $34.88 per share, resulting in proceeds of $17,753. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.4K

0% 3M change

0% 12M change

Total Value Held $870,504

ROY WINSTON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 02 2023	SELL Open market or private sale	$17,753 $34.88 p/Share	509 Reduced 0.96%	52,440 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	10,950 Added 17.31%	52,306 Common Stock
Jun 07 2023	SELL Open market or private sale	$70,324 $37.87 p/Share	1,857 Reduced 4.3%	41,356 Common Stock
Jun 06 2023	SELL Open market or private sale	$69,363 $38.99 p/Share	1,779 Reduced 3.95%	43,213 Common Stock
Aug 03 2022	SELL Open market or private sale	$26,513 $55.7 p/Share	476 Reduced 1.05%	44,992 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	9,900 Added 18.01%	45,060 Common Stock
Jun 06 2022	SELL Open market or private sale	$1,087,150 $61.96 p/Share	17,546 Reduced 33.29%	35,160 Common Stock
Jun 06 2022	BUY Exercise of conversion of derivative security	$214,875 $34.38 p/Share	6,250 Added 10.99%	50,607 Common Stock
Nov 04 2021	BUY Exercise of conversion of derivative security	$481,500 $48.15 p/Share	10,000 Added 17.71%	46,456 Common Stock
Aug 03 2021	BUY Grant, award, or other acquisition	-	5,000 Added 12.06%	36,456 Common Stock
Jun 09 2021	BUY Grant, award, or other acquisition	-	7,000 Added 18.4%	31,035 Common Stock
Jun 04 2021	SELL Open market or private sale	$138,927 $61.04 p/Share	2,276 Reduced 8.65%	24,035 Common Stock
Mar 31 2021	SELL Open market or private sale	$1,582,127 $71.19 p/Share	22,224 Reduced 45.79%	26,311 Common Stock
Mar 31 2021	BUY Exercise of conversion of derivative security	$472,725 $34.38 p/Share	13,750 Added 22.08%	48,535 Common Stock
Nov 13 2020	SELL Open market or private sale	$310,000 $62.0 p/Share	5,000 Reduced 12.57%	34,785 Common Stock

Roy Winston

Chief Medical Officer

Tampa, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Pacira BioSciences, Inc.

Track Activities on PCRX

Account